Cancer drug developer Erasca amasses $64 mln
San Diego-based Erasca, a cancer drug developer, has raised $64 million in Series A financing round. The investors included ARCH Venture Partners, Andreessen Horowitz and Reneo Capital.
5 March 2019•1 min read
